AMERICAN ORIENTAL BIOENGINEERING INC
DelistedCIK 1090514fmd_0K3N8QA08P41B0C68SRPZW4F02Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2013, 15 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 |
|---|---|---|---|---|
| Total revenues | 296 | 306 | 213 | 145 |
| Cost of revenue | 129 | 148 | 113 | 101 |
| Net interest income | (6) | (6) | (7) | (6) |
| Gross profit | 167 | 158 | 100 | 44 |
| Research and development | 8 | 15 | 13 | 6 |
| Selling, general and administrative | 62 | 66 | 51 | 50 |
| Total operating expenses | 108 | 127 | 143 | 131 |
| Operating income | 59 | 30 | (43) | (86) |
| Interest expense | – | 6 | 6 | 4 |
| Other non-operating income (expense) | (1) | (0) | 0 | 0 |
| Income before taxes | 55 | 23 | (68) | (58) |
| Income tax expense | 13 | 9 | 1 | 2 |
| Net income from continuing operations | 41 | 14 | (68) | (60) |
| Net income | 41 | 14 | (67) | (60) |